BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11591288)

  • 1. [Use of esmolol in patient with portal hypertension].
    Figueroa Yusta J; Gilsanz F; De Dios Tomás E
    Rev Esp Anestesiol Reanim; 2001; 48(7):349. PubMed ID: 11591288
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy and prevention of hemorrhage in esophageal and gastric varices].
    Kitsenko EA; Peresta IuIu
    Klin Med (Mosk); 1995; 73(2):12-6. PubMed ID: 7541875
    [No Abstract]   [Full Text] [Related]  

  • 3. [The drug therapy of upper gastrointestinal bleeding in portal hypertension].
    Holstege A
    Dtsch Med Wochenschr; 1994 Jun; 119(25-26):917-22. PubMed ID: 8020390
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological treatment of portal hypertension.
    Patch D; Burroughs AK
    Prog Liver Dis; 1995; 13():269-92. PubMed ID: 9224506
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-blockers to prevent esophageal varices--an unfulfilled promise.
    Mukherjee S; Sorrell MF
    N Engl J Med; 2005 Nov; 353(21):2288-90. PubMed ID: 16306528
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug treatment of bleeding esophageal varices. Acute therapy and prevention of recurrence].
    Maier KP
    Dtsch Med Wochenschr; 1986 Feb; 111(8):306-13. PubMed ID: 2868875
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug therapy for portal hypertension.
    Lebrec D
    Gut; 2001 Sep; 49(3):441-2. PubMed ID: 11511569
    [No Abstract]   [Full Text] [Related]  

  • 8. [What is the treatment of choice in a patient with liver cirrhosis and esophageal varices that have bled to prevent rebleeding: beta-blockers, endoscopic ligation or both?].
    Albillos Martínez A
    Gastroenterol Hepatol; 2009 Feb; 32(2):124-5. PubMed ID: 19231689
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pharmacologic treatment of portal hypertension].
    Guevara L
    Rev Gastroenterol Mex; 1984; 49(4):207-9. PubMed ID: 6152355
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.
    Gatta A; Sacerdoti D; Merkel C; Milani L; Battaglia G; Zuin R
    Am Heart J; 1984 Oct; 108(4 Pt 2):1167-72. PubMed ID: 6148880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G
    J Clin Gastroenterol; 2007; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophagogastric variceal bleeding in cirrhotic portal hypertension: consensus on prevention and management (2008).
    Cheng LF; Jia JD; Xu XY; Linghu EQ; Liu YL; Leng XS; Wang MQ; ; ;
    Chin Med J (Engl); 2009 Apr; 122(7):766-75. PubMed ID: 19493387
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of portal hypertension].
    Geller LI
    Klin Med (Mosk); 1991 Apr; 69(4):28-32. PubMed ID: 1865644
    [No Abstract]   [Full Text] [Related]  

  • 14. [Somatostatin, octreotide and portal hypertension].
    Silvain C; Besson I; Beauchant M
    Gastroenterol Clin Biol; 1994; 18(8-9):761-6. PubMed ID: 7875447
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-blockers to prevent gastroesophageal varices in cirrhosis.
    Post AB
    N Engl J Med; 2006 Mar; 354(12):1318-20; author reply 1318-20. PubMed ID: 16554538
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-blockers in the prevention of gastrointestinal bleeding.
    Lebrec L
    Rev Invest Clin; 1990 Jul; 42 Suppl():159-64. PubMed ID: 19256157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of beta blockers in preventing hemorrhages from esophageal varices. A hemodynamic study].
    Santambrogio R; Galeotti F; Opocher E; Cucchiaro G; Cornalba GP; Rota L; Ferrario M; Fumagalli U; Spina GP
    Minerva Med; 1986 Mar; 77(12):429-32. PubMed ID: 2871526
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of propranolol on portal hypertension].
    Kovacević N; Tomić D; Perisić-Savić M; Grbić R
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic assessment of pharmacological response in the treatment of portal hypertension: a need to know.
    Grace ND
    Am J Gastroenterol; 2000 Aug; 95(8):1862-4. PubMed ID: 10950027
    [No Abstract]   [Full Text] [Related]  

  • 20. Portal hypertension: pre-primary and primary prophylaxis of variceal bleeding.
    Tiani C; Abraldes JG; Bosch J
    Dig Liver Dis; 2008 May; 40(5):318-27. PubMed ID: 18291732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.